Saw Palmetto, BPH Study Backed By $1.6 Mil. In NIDDK Funding
This article was originally published in The Tan Sheet
Executive Summary
Researchers at the University of California-San Francisco expect to complete enrollment for a study on the effects of saw palmetto in alleviating symptoms of benign prostatic hyperplasia (BPH) in June
You may also be interested in...
Saw Palmetto Efficacy For BPH Symptoms Slated For NIH Clinical Study
Three NIH divisions plan to spend a combined $29 mil. over the next seven years to study the efficacy of saw palmetto and Pygeum africanum on relieving symptoms associated with benign prostatic hyperplasia
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands